9.98
1.33 (15.38%)
| Penutupan Terdahulu | 8.65 |
| Jumlah Dagangan | 1,833,886 |
| Harga / Buku (P/B) | 1.25 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.69 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.13% |
| Nisbah Semasa (MRQ) | 24.62 |
| Aliran Tunai Operasi (OCF TTM) | -88.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Bicara Therapeutics Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Nilai 35% | 0.0 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 0.0 |
| Masa 35% | -1.1 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | 1.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -22.5% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 3.0 |
| Skor Akhir | -0.47 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.65% |
| % Dimiliki oleh Institusi | 89.28% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Red Tree Management, Llc | 30 Sep 2026 | 2,920,509 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |